Get started
Author

Kim Vietz Andreassen

Observed names: Andreassen, Kim, K. Andreassen, K. V. Andreassen, K.V. Andreassen, K.V. Andreassen⁎, K.W. Andreassen, KIM V. ANDREASSEN, KV Andreassen, Kim Andreassen, Kim V Andreassen, Kim V. Andreassen
Observed institution: Nordic Bioscience (Denmark)
OpenAlex ID: A5109274291
Prolonged Calcitonin Receptor Signaling by Salmon, but Not Human Calcitonin, Reveals Ligand Bias
2014 · Kim Vietz Andreassen, Sara Toftegaard Hjuler, et al. · PLoS ONE · 89
PDF
A novel oral dual amylin and calcitonin receptor agonist (KBP-042) exerts antiobesity and antidiabetic effects in rats
2014 · Kim V. Andreassen, Michael Feigh, et al. · American Journal of Physiology-Endocrinology and Metabolism · 71
A novel dual amylin and calcitonin receptor agonist, KBP‐089, induces weight loss through a reduction in fat, but not lean mass, while improving food preference
2017 · Sofie Gydesen, Sara Toftegaard Hjuler, et al. · British Journal of Pharmacology · 64
PDF
KBP-088, a novel DACRA with prolonged receptor activation, is superior to davalintide in terms of efficacy on body weight
2016 · Sofie Gydesen, Kim Vietz Andreassen, et al. · American Journal of Physiology-Endocrinology and Metabolism · 58
A novel oral form of salmon calcitonin improves glucose homeostasis and reduces body weight in diet‐induced obese rats
2011 · M. Feigh, K. Henriksen, et al. · Diabetes Obesity and Metabolism · 46
The dual amylin‐ and calcitonin‐receptor agonist KBP‐042 increases insulin sensitivity and induces weight loss in rats with obesity
2016 · Sara Toftegaard Hjuler, Sofie Gydesen, et al. · Obesity · 45
PDF
KBP-066A, a long-acting dual amylin and calcitonin receptor agonist, induces weight loss and improves glycemic control in obese and diabetic rats
2021 · K.V. Andreassen, A.T. Larsen, et al. · Molecular Metabolism · 39
PDF
KBP-042 improves bodyweight and glucose homeostasis with indices of increased insulin sensitivity irrespective of route of administration
2015 · Sara T. Hjuler, Kim V. Andreassen, et al. · European Journal of Pharmacology · 39
The Calcitonin Receptor Plays a Major Role in Glucose Regulation as a Function of Dual Amylin and Calcitonin Receptor Agonist Therapy
2020 · Anna Thorsø Larsen, Nina Sonne, et al. · Journal of Pharmacology and Experimental Therapeutics · 34
PDF
The Dual Amylin and Calcitonin Receptor Agonist KBP-088 Induces Weight Loss and Improves Insulin Sensitivity Superior to Chronic Amylin Therapy
2019 · Anna Thorsø Larsen, Nina Sonne, et al. · Journal of Pharmacology and Experimental Therapeutics · 34
PDF
Optimization of tolerability and efficacy of the novel dual amylin and calcitonin receptor agonist KBP-089 through dose escalation and combination with a GLP-1 analog
2017 · Sofie Gydesen, Kim Vietz Andreassen, et al. · American Journal of Physiology-Endocrinology and Metabolism · 34
PDF
Investigation of chondrocyte hypertrophy and cartilage calcification in a full-depth articular cartilage explants model
2012 · Pingping Chen-An, Kim Vietz Andreassen, et al. · Rheumatology International · 33
The Dual Amylin- and Calcitonin-Receptor Agonist KBP-042 Works as Adjunct to Metformin on Fasting Hyperglycemia and HbA1c in a Rat Model of Type 2 Diabetes
2017 · Sara T. Hjuler, Sofie Gydesen, et al. · Journal of Pharmacology and Experimental Therapeutics · 29
PDF
A specific subtype of osteoclasts secretes factors inducing nodule formation by osteoblasts
2012 · K. Henriksen⁎, K.V. Andreassen, et al. · Bone · 28
A dual amylin and calcitonin receptor agonist inhibits pain behavior and reduces cartilage pathology in an osteoarthritis rat model
2019 · A. Katri, A. Dąbrowska, et al. · Osteoarthritis and Cartilage · 25
Oral salmon calcitonin attenuates hyperglycaemia and preserves pancreatic beta‐cell area and function in Zucker diabetic fatty rats
2012 · M Feigh, KV Andreassen, et al. · British Journal of Pharmacology · 23
Combining naproxen and a dual amylin and calcitonin receptor agonist improves pain and structural outcomes in the collagen-induced arthritis rat model
2019 · Anna Katri, Aneta Dąbrowska, et al. · Arthritis Research & Therapy · 21
PDF
Future detection and monitoring of diabetes may entail analysis of both β-cell function and volume: How markers of β-cell loss may assist
2012 · Anita V Neutzsky-Wulff, Kim V Andreassen, et al. · Journal of Translational Medicine · 21
PDF
Oral salmon calcitonin protects against impaired fasting glycemia, glucose intolerance, and obesity induced by high-fat diet and ovariectomy in rats
2013 · Michael Feigh, Kim V. Andreassen, et al. · Menopause The Journal of The North American Menopause Society · 20
Oral salmon calcitonin enhances insulin action and glucose metabolism in diet-induced obese streptozotocin-diabetic rats
2014 · Michael Feigh, Sara T. Hjuler, et al. · European Journal of Pharmacology · 18
Dose Frequency Optimization of the Dual Amylin and Calcitonin Receptor Agonist KBP-088: Long-Lasting Improvement in Food Preference and Body Weight Loss
2020 · Anna Thorsø Larsen, Nina Sonne, et al. · Journal of Pharmacology and Experimental Therapeutics · 17
PDF
The Dual Amylin and Calcitonin Receptor Agonist, KBP-066, Induces an Equally Potent Weight Loss Across a Broad Dose Range While Higher Doses May Further Improve Insulin Action
2020 · Nina Sonne, Anna Thorsø Larsen, et al. · Journal of Pharmacology and Experimental Therapeutics · 17
PDF
OXM-104, a potential candidate for the treatment of obesity, NASH and type 2 diabetes
2023 · Simone Anna Melander, Ashref Kayed, et al. · European Journal of Pharmacology · 11
PDF
Glucocorticoids exert context-dependent effects on cells of the joint in vitro
2011 · Suzi H. Madsen, Kim V. Andreassen, et al. · Steroids · 11
The Effects of Dual GLP-1/Glucagon Receptor Agonists with Different Receptor Selectivity in Mouse Models of Obesity and Nonalcoholic Steatohepatitis
2022 · Ashref Kayed, Simone Anna Melander, et al. · Journal of Pharmacology and Experimental Therapeutics · 7
PDF
Works count: 48
Citation count: 844
H-index: 19
I10-index: 24
Year
Topic
Type